Creation and application of psychoactive designer drugs data library using liquid chromatography with photodiode array spectrophotometry detector and gas chromatography–mass spectrometry

In order to quickly confirm a potentially hazardous psychoactive designer drug (a compound in which part of the molecular structure of a stimulant or narcotic has been modified), we created a psychoactive drugs data library by performing analysis using liquid chromatography with photodiode array spe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Talanta (Oxford) 2009-02, Vol.77 (4), p.1245-1272
Hauptverfasser: Takahashi, Misako, Nagashima, Machiko, Suzuki, Jin, Seto, Takako, Yasuda, Ichirou, Yoshida, Takemi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1272
container_issue 4
container_start_page 1245
container_title Talanta (Oxford)
container_volume 77
creator Takahashi, Misako
Nagashima, Machiko
Suzuki, Jin
Seto, Takako
Yasuda, Ichirou
Yoshida, Takemi
description In order to quickly confirm a potentially hazardous psychoactive designer drug (a compound in which part of the molecular structure of a stimulant or narcotic has been modified), we created a psychoactive drugs data library by performing analysis using liquid chromatography with photodiode array spectrophotometry (LC/PDA) and gas chromatography–mass spectrometry (GC/MS). The data in this library consist of the LC capacity factor ( k′) ratios in relation to the internal standard, the ultraviolet (UV) spectra and the MS spectra of 104 compounds. By performing a comparative study of the data in this report with the analytical data for commercial and illegal drug products, it is possible to quickly identify the psychoactive designer drugs in 205 purchased products by using the library. Further, it is possible to analogize the structure of drugs for which there is no matching data in the library using similar data. Furthermore, when structural isomers of controlled substances have detected from the presented library, similarity of their biological effects on human will be predicted, thus leading to regulate their public circulation. Examples of these types of isomers include, for instance, the narcotic 3,4,5-trimethoxyamphetamine (TMA) and its positional isomers 2,4,5-trimethoxyamphetamine (TMA-2) and 2,4,6-trimethoxyamphetamine (TMA-6), or the narcotic 1-(3-chlorophenyl)piperazine (3CPP) and its isomers 1-( o-chlorophenyl)piperazine (2CPP) and 1-( p-chlorophenyl)piperazine (4CPP). Differentiation of these compounds is necessary in regulating them, and we report here the results of a study of a method to confirm these compounds using the present library.
doi_str_mv 10.1016/j.talanta.2008.07.062
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66740455</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0039914008005808</els_id><sourcerecordid>66740455</sourcerecordid><originalsourceid>FETCH-LOGICAL-c393t-19f168b538721938761bff6aad8bea391ad8f7ef26f3bbfe03f194306a99a1c73</originalsourceid><addsrcrecordid>eNqFUcuO1DAQjBCIHRY-AeQL3BLsOJPEJ4RGvKSVuMDZ6tjtiUdJnLWdXc2Nf-B3-Bq-BM9MAIkLl3Z3q6rcqsqy54wWjLL69aGIMMAUoSgpbQvaFLQuH2Qb1jY859uGP8w2lHKRC1bRq-xJCAdKackpf5xdMUHbquZ8k_3YeYRo3URg0gTmebDqMjtD5nBUvQMV7R0SjcHuJ_RE-2UfiIYIZLCdB38kS7DTPk23i9VE9d6NEN3ew9wfyb2NPZl7F522TiMB7-FIwowqenfejxiThsaYVs6fD9lD-Efn57fvI4Twm3jmPM0eGRgCPlvf6-zr-3dfdh_zm88fPu3e3uSKCx5zJgyr227L26ZkItWadcbUALrtELhgqTENmrI2vOsMUm6YqDitQQhgquHX2auL7uzd7YIhytEGhUPyH90SZF03Fa222wTcXoDKuxA8Gjl7OyaHJKPyFJs8yDU2eYpN0kam2BLvxfrB0o2o_7LWnBLg5QqAoGAwHiZlwx9cyVhLBT8JvbngMNlxZ9HLoCxOCrX1yTepnf3PKb8AczzBWw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66740455</pqid></control><display><type>article</type><title>Creation and application of psychoactive designer drugs data library using liquid chromatography with photodiode array spectrophotometry detector and gas chromatography–mass spectrometry</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Takahashi, Misako ; Nagashima, Machiko ; Suzuki, Jin ; Seto, Takako ; Yasuda, Ichirou ; Yoshida, Takemi</creator><creatorcontrib>Takahashi, Misako ; Nagashima, Machiko ; Suzuki, Jin ; Seto, Takako ; Yasuda, Ichirou ; Yoshida, Takemi</creatorcontrib><description>In order to quickly confirm a potentially hazardous psychoactive designer drug (a compound in which part of the molecular structure of a stimulant or narcotic has been modified), we created a psychoactive drugs data library by performing analysis using liquid chromatography with photodiode array spectrophotometry (LC/PDA) and gas chromatography–mass spectrometry (GC/MS). The data in this library consist of the LC capacity factor ( k′) ratios in relation to the internal standard, the ultraviolet (UV) spectra and the MS spectra of 104 compounds. By performing a comparative study of the data in this report with the analytical data for commercial and illegal drug products, it is possible to quickly identify the psychoactive designer drugs in 205 purchased products by using the library. Further, it is possible to analogize the structure of drugs for which there is no matching data in the library using similar data. Furthermore, when structural isomers of controlled substances have detected from the presented library, similarity of their biological effects on human will be predicted, thus leading to regulate their public circulation. Examples of these types of isomers include, for instance, the narcotic 3,4,5-trimethoxyamphetamine (TMA) and its positional isomers 2,4,5-trimethoxyamphetamine (TMA-2) and 2,4,6-trimethoxyamphetamine (TMA-6), or the narcotic 1-(3-chlorophenyl)piperazine (3CPP) and its isomers 1-( o-chlorophenyl)piperazine (2CPP) and 1-( p-chlorophenyl)piperazine (4CPP). Differentiation of these compounds is necessary in regulating them, and we report here the results of a study of a method to confirm these compounds using the present library.</description><identifier>ISSN: 0039-9140</identifier><identifier>EISSN: 1873-3573</identifier><identifier>DOI: 10.1016/j.talanta.2008.07.062</identifier><identifier>PMID: 19084633</identifier><identifier>CODEN: TLNTA2</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Amphetamines - analysis ; Analytical chemistry ; Chemistry ; Chromatographic methods and physical methods associated with chromatography ; Chromatography, Liquid - methods ; Designer Drugs - analysis ; Exact sciences and technology ; Gas chromatographic methods ; Gas Chromatography-Mass Spectrometry - methods ; GC/MS ; General, instrumentation ; LC/PDA ; Models, Chemical ; Narcotics - analysis ; Other chromatographic methods ; Pharmaceutical Preparations - analysis ; Phenylethylamine ; Piperazine ; Piperazines - analysis ; Psychoactive designer drug ; Psychotropic Drugs - analysis ; Spectrometric and optical methods ; Spectrophotometry - methods ; Tryptamine ; Ultraviolet Rays</subject><ispartof>Talanta (Oxford), 2009-02, Vol.77 (4), p.1245-1272</ispartof><rights>2008 Elsevier B.V.</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c393t-19f168b538721938761bff6aad8bea391ad8f7ef26f3bbfe03f194306a99a1c73</citedby><cites>FETCH-LOGICAL-c393t-19f168b538721938761bff6aad8bea391ad8f7ef26f3bbfe03f194306a99a1c73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.talanta.2008.07.062$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21180932$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19084633$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Takahashi, Misako</creatorcontrib><creatorcontrib>Nagashima, Machiko</creatorcontrib><creatorcontrib>Suzuki, Jin</creatorcontrib><creatorcontrib>Seto, Takako</creatorcontrib><creatorcontrib>Yasuda, Ichirou</creatorcontrib><creatorcontrib>Yoshida, Takemi</creatorcontrib><title>Creation and application of psychoactive designer drugs data library using liquid chromatography with photodiode array spectrophotometry detector and gas chromatography–mass spectrometry</title><title>Talanta (Oxford)</title><addtitle>Talanta</addtitle><description>In order to quickly confirm a potentially hazardous psychoactive designer drug (a compound in which part of the molecular structure of a stimulant or narcotic has been modified), we created a psychoactive drugs data library by performing analysis using liquid chromatography with photodiode array spectrophotometry (LC/PDA) and gas chromatography–mass spectrometry (GC/MS). The data in this library consist of the LC capacity factor ( k′) ratios in relation to the internal standard, the ultraviolet (UV) spectra and the MS spectra of 104 compounds. By performing a comparative study of the data in this report with the analytical data for commercial and illegal drug products, it is possible to quickly identify the psychoactive designer drugs in 205 purchased products by using the library. Further, it is possible to analogize the structure of drugs for which there is no matching data in the library using similar data. Furthermore, when structural isomers of controlled substances have detected from the presented library, similarity of their biological effects on human will be predicted, thus leading to regulate their public circulation. Examples of these types of isomers include, for instance, the narcotic 3,4,5-trimethoxyamphetamine (TMA) and its positional isomers 2,4,5-trimethoxyamphetamine (TMA-2) and 2,4,6-trimethoxyamphetamine (TMA-6), or the narcotic 1-(3-chlorophenyl)piperazine (3CPP) and its isomers 1-( o-chlorophenyl)piperazine (2CPP) and 1-( p-chlorophenyl)piperazine (4CPP). Differentiation of these compounds is necessary in regulating them, and we report here the results of a study of a method to confirm these compounds using the present library.</description><subject>Amphetamines - analysis</subject><subject>Analytical chemistry</subject><subject>Chemistry</subject><subject>Chromatographic methods and physical methods associated with chromatography</subject><subject>Chromatography, Liquid - methods</subject><subject>Designer Drugs - analysis</subject><subject>Exact sciences and technology</subject><subject>Gas chromatographic methods</subject><subject>Gas Chromatography-Mass Spectrometry - methods</subject><subject>GC/MS</subject><subject>General, instrumentation</subject><subject>LC/PDA</subject><subject>Models, Chemical</subject><subject>Narcotics - analysis</subject><subject>Other chromatographic methods</subject><subject>Pharmaceutical Preparations - analysis</subject><subject>Phenylethylamine</subject><subject>Piperazine</subject><subject>Piperazines - analysis</subject><subject>Psychoactive designer drug</subject><subject>Psychotropic Drugs - analysis</subject><subject>Spectrometric and optical methods</subject><subject>Spectrophotometry - methods</subject><subject>Tryptamine</subject><subject>Ultraviolet Rays</subject><issn>0039-9140</issn><issn>1873-3573</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUcuO1DAQjBCIHRY-AeQL3BLsOJPEJ4RGvKSVuMDZ6tjtiUdJnLWdXc2Nf-B3-Bq-BM9MAIkLl3Z3q6rcqsqy54wWjLL69aGIMMAUoSgpbQvaFLQuH2Qb1jY859uGP8w2lHKRC1bRq-xJCAdKackpf5xdMUHbquZ8k_3YeYRo3URg0gTmebDqMjtD5nBUvQMV7R0SjcHuJ_RE-2UfiIYIZLCdB38kS7DTPk23i9VE9d6NEN3ew9wfyb2NPZl7F522TiMB7-FIwowqenfejxiThsaYVs6fD9lD-Efn57fvI4Twm3jmPM0eGRgCPlvf6-zr-3dfdh_zm88fPu3e3uSKCx5zJgyr227L26ZkItWadcbUALrtELhgqTENmrI2vOsMUm6YqDitQQhgquHX2auL7uzd7YIhytEGhUPyH90SZF03Fa222wTcXoDKuxA8Gjl7OyaHJKPyFJs8yDU2eYpN0kam2BLvxfrB0o2o_7LWnBLg5QqAoGAwHiZlwx9cyVhLBT8JvbngMNlxZ9HLoCxOCrX1yTepnf3PKb8AczzBWw</recordid><startdate>20090215</startdate><enddate>20090215</enddate><creator>Takahashi, Misako</creator><creator>Nagashima, Machiko</creator><creator>Suzuki, Jin</creator><creator>Seto, Takako</creator><creator>Yasuda, Ichirou</creator><creator>Yoshida, Takemi</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20090215</creationdate><title>Creation and application of psychoactive designer drugs data library using liquid chromatography with photodiode array spectrophotometry detector and gas chromatography–mass spectrometry</title><author>Takahashi, Misako ; Nagashima, Machiko ; Suzuki, Jin ; Seto, Takako ; Yasuda, Ichirou ; Yoshida, Takemi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c393t-19f168b538721938761bff6aad8bea391ad8f7ef26f3bbfe03f194306a99a1c73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Amphetamines - analysis</topic><topic>Analytical chemistry</topic><topic>Chemistry</topic><topic>Chromatographic methods and physical methods associated with chromatography</topic><topic>Chromatography, Liquid - methods</topic><topic>Designer Drugs - analysis</topic><topic>Exact sciences and technology</topic><topic>Gas chromatographic methods</topic><topic>Gas Chromatography-Mass Spectrometry - methods</topic><topic>GC/MS</topic><topic>General, instrumentation</topic><topic>LC/PDA</topic><topic>Models, Chemical</topic><topic>Narcotics - analysis</topic><topic>Other chromatographic methods</topic><topic>Pharmaceutical Preparations - analysis</topic><topic>Phenylethylamine</topic><topic>Piperazine</topic><topic>Piperazines - analysis</topic><topic>Psychoactive designer drug</topic><topic>Psychotropic Drugs - analysis</topic><topic>Spectrometric and optical methods</topic><topic>Spectrophotometry - methods</topic><topic>Tryptamine</topic><topic>Ultraviolet Rays</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Takahashi, Misako</creatorcontrib><creatorcontrib>Nagashima, Machiko</creatorcontrib><creatorcontrib>Suzuki, Jin</creatorcontrib><creatorcontrib>Seto, Takako</creatorcontrib><creatorcontrib>Yasuda, Ichirou</creatorcontrib><creatorcontrib>Yoshida, Takemi</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Talanta (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Takahashi, Misako</au><au>Nagashima, Machiko</au><au>Suzuki, Jin</au><au>Seto, Takako</au><au>Yasuda, Ichirou</au><au>Yoshida, Takemi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Creation and application of psychoactive designer drugs data library using liquid chromatography with photodiode array spectrophotometry detector and gas chromatography–mass spectrometry</atitle><jtitle>Talanta (Oxford)</jtitle><addtitle>Talanta</addtitle><date>2009-02-15</date><risdate>2009</risdate><volume>77</volume><issue>4</issue><spage>1245</spage><epage>1272</epage><pages>1245-1272</pages><issn>0039-9140</issn><eissn>1873-3573</eissn><coden>TLNTA2</coden><abstract>In order to quickly confirm a potentially hazardous psychoactive designer drug (a compound in which part of the molecular structure of a stimulant or narcotic has been modified), we created a psychoactive drugs data library by performing analysis using liquid chromatography with photodiode array spectrophotometry (LC/PDA) and gas chromatography–mass spectrometry (GC/MS). The data in this library consist of the LC capacity factor ( k′) ratios in relation to the internal standard, the ultraviolet (UV) spectra and the MS spectra of 104 compounds. By performing a comparative study of the data in this report with the analytical data for commercial and illegal drug products, it is possible to quickly identify the psychoactive designer drugs in 205 purchased products by using the library. Further, it is possible to analogize the structure of drugs for which there is no matching data in the library using similar data. Furthermore, when structural isomers of controlled substances have detected from the presented library, similarity of their biological effects on human will be predicted, thus leading to regulate their public circulation. Examples of these types of isomers include, for instance, the narcotic 3,4,5-trimethoxyamphetamine (TMA) and its positional isomers 2,4,5-trimethoxyamphetamine (TMA-2) and 2,4,6-trimethoxyamphetamine (TMA-6), or the narcotic 1-(3-chlorophenyl)piperazine (3CPP) and its isomers 1-( o-chlorophenyl)piperazine (2CPP) and 1-( p-chlorophenyl)piperazine (4CPP). Differentiation of these compounds is necessary in regulating them, and we report here the results of a study of a method to confirm these compounds using the present library.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>19084633</pmid><doi>10.1016/j.talanta.2008.07.062</doi><tpages>28</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0039-9140
ispartof Talanta (Oxford), 2009-02, Vol.77 (4), p.1245-1272
issn 0039-9140
1873-3573
language eng
recordid cdi_proquest_miscellaneous_66740455
source MEDLINE; Elsevier ScienceDirect Journals
subjects Amphetamines - analysis
Analytical chemistry
Chemistry
Chromatographic methods and physical methods associated with chromatography
Chromatography, Liquid - methods
Designer Drugs - analysis
Exact sciences and technology
Gas chromatographic methods
Gas Chromatography-Mass Spectrometry - methods
GC/MS
General, instrumentation
LC/PDA
Models, Chemical
Narcotics - analysis
Other chromatographic methods
Pharmaceutical Preparations - analysis
Phenylethylamine
Piperazine
Piperazines - analysis
Psychoactive designer drug
Psychotropic Drugs - analysis
Spectrometric and optical methods
Spectrophotometry - methods
Tryptamine
Ultraviolet Rays
title Creation and application of psychoactive designer drugs data library using liquid chromatography with photodiode array spectrophotometry detector and gas chromatography–mass spectrometry
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T14%3A58%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Creation%20and%20application%20of%20psychoactive%20designer%20drugs%20data%20library%20using%20liquid%20chromatography%20with%20photodiode%20array%20spectrophotometry%20detector%20and%20gas%20chromatography%E2%80%93mass%20spectrometry&rft.jtitle=Talanta%20(Oxford)&rft.au=Takahashi,%20Misako&rft.date=2009-02-15&rft.volume=77&rft.issue=4&rft.spage=1245&rft.epage=1272&rft.pages=1245-1272&rft.issn=0039-9140&rft.eissn=1873-3573&rft.coden=TLNTA2&rft_id=info:doi/10.1016/j.talanta.2008.07.062&rft_dat=%3Cproquest_cross%3E66740455%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=66740455&rft_id=info:pmid/19084633&rft_els_id=S0039914008005808&rfr_iscdi=true